Scott A. Kelly
2022
In 2022, Scott A. Kelly earned a total compensation of $2.5M as Chief Medical Officer at CytoDyn, a 26% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,877,750 |
|---|---|
| Salary | $554,531 |
| Stock Awards | $30,470 |
| Other | $16,636 |
| Total | $2,479,387 |
Kelly received $1.9M in option awards, accounting for 76% of the total pay in 2022.
Kelly also received $554.5K in salary, $30.5K in stock awards and $16.6K in other compensation.
Rankings
In 2022, Scott A. Kelly's compensation ranked 1,468th out of 5,760 executives tracked by ExecPay. In other words, Kelly earned more than 74.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,468 out of 5,760 | 75th |
Division Manufacturing | 735 out of 3,136 | 77th |
Major group Chemicals And Allied Products | 286 out of 1,422 | 80th |
Industry group Drugs | 265 out of 1,323 | 80th |
Industry Pharmaceutical Preparations | 188 out of 969 | 81st |
Source: SEC filing on October 26, 2022.
Kelly's colleagues
We found four more compensation records of executives who worked with Scott A. Kelly at CytoDyn in 2022.